SANGAMO THERAPEUTICS, INC. (SGMOQ) Return on equity 2016–2024
SANGAMO THERAPEUTICS, INC. (SGMOQ) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-430.1%FY2024 · since FY2016: -52.6% → -430.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -430.1% | -119.1 pp |
| FY2023 | -311.1% | -245.9 pp |
| FY2022 | -65.2% | -17.7 pp |
| FY2021 | -47.5% | -23.2 pp |
| FY2020 | -24.3% | -2.3 pp |
| FY2019 | -22.0% | -3.4 pp |
| FY2018 | -18.6% | +10.4 pp |
| FY2017 | -29.0% | +23.6 pp |
| FY2016 | -52.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice